癌症是一个比较综合类的疾病。癌症的魔爪不分性别、年龄、种族或是社会经济背景的差异伸向各类人群之中。
癌症不只是迅速分裂细胞,而是一个能让世界范围内超过八百万人死亡的主要原因。
在此,我们提出一些有建设性的讨论,由资深的癌症研究专家与我们分享他们在运用科学和技术进行抗癌研究的洞悉。
先来个小测,你真的了解癌症么?
期刊主编与BioMed Central编辑的超级Q&A
在这个部分,我们推出期刊Cancer Cell International、Clinical Proteomics、Vascular Cell三位主编与BioMed Central编辑们的精彩问答。这三位主编分别从科技与癌症、中美癌症研究比较、以及科学联合与癌症研究等几个方面谈了谈他们个人的观点。
精彩文章集锦
- Relevance of tumor-infiltrating lymphocytes in breast cancer
- Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
- New horizons in tumor microenvironment biology: challenges and opportunities
- Characterization of interaction of magnetic nanoparticles with breast cancer cells
- The effects of multifunctional MiR-122-loaded graphene-gold composites on drug-resistant liver cancer
- Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells
- Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis
- Silicon particles as trojan horses for potential cancer therapy
- CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
- Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells
- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- Widespread intron retention diversifies most cancer transcriptomes
- Mutation signatures implicate aristolochic acid in bladder cancer development
- Development of cancer genetic services in the UK: A national consultation
- Altering cancer transcriptomes using epigenomic inhibitors
- Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis
- Autophagy capacity and sub-mitochondrial heterogeneity shape Bnip3-induced mitophagy regulation of apoptosis
- Cancer stem cells – the current status of an old concept: literature review and clinical approaches
- A colorectal cancer prediction model using traditional and genetic risk scores in Koreans
- Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
- Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
- Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
- Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
- Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation
更多来自SpringerOpen平台的精彩内容
- Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer
- New prospects for PET in prostate cancer imaging: a physicist's viewpoint
- Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
- Managing the advanced cancer patient in the Australian emergency department environment: findings from a national survey of emergency department clinicians
- Pectoral nerve block combined with general anesthesia for breast cancer surgery: a retrospective comparison
- Cancer therapy: know your enemy?
- Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
- Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways
发现BioMed Central与癌症研究相关的期刊
- Biological Research
- Biomarker Research
- BMC Cancer
- BMC Genomics
- BMC Medicine
- Breast Cancer Research
- Cancer & Metabolism
- Cancer Cell International
- Cancer Imaging
- Cell Communication and Signaling
- Cell Division
- Cilia
- Clinical Proteomics
- Epigenetics & Chromatin
- Genome Biology
- Genome Medicine
- Journal of Nanobiotechnology
- Molecular Cancer
- Vascular Cell
最后别忘了,试试我们的期刊选择自助平台,journal selector,find the right journal for you.